跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 62 条关于
“Ga68-PentixaFor”
全部
62
临床试验
47
药物
6
机构
0
资讯
9
去年
Pentixapharm's Ga68-PentixaFor Receives EMA PRIME Status for Primary Aldosteronism Diagnosis
去年
Novel Radioligand Therapy Shows Complete Response in Muscle-Invasive Bladder Cancer Patient
去年
NCI and NIDDK Initiate Phase II Trial of PentixaFor for Adrenal Tumor Subtyping
9个月前
Pentixapharm Receives FDA Guidance for Phase 3 PANDA Study of 68Ga-PentixaFor in Primary Aldosteronism
11个月前
Pentixapharm's CXCR4-Targeted Radiopharmaceuticals Show Promise in Primary Aldosteronism and Bladder Cancer
4个月前
Pentixapharm Submits IND to FDA for Phase 3 PANDA Trial of First-in-Class CXCR4-Targeted Cardiovascular Diagnostic
6个月前
Pentixapharm Receives FDA Approval for CXCR4-Targeted Radiotheranostic Program in Blood Cancers
去年
Pentixapharm Pivots Clinical Strategy to Focus on CXCR4-Targeted Theranostic Oncology Platform
2个月前
Peptide Ligand Discovery for GPCRs: A Comprehensive Primer on Methods, Tools, and Therapeutic Opportunities